• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Vazegepant HCl Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759463

Vazegepant is the first intranasal gepant for the acute treatment,of migraine and has announced a positive phase II/III study. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Vazegepant HCl, Inhibitor
Full Product Name
Vazegepant HCl
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
675.3
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C36H47ClN8O3
SMILES
Cl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
CAS Number
1414976-20-7
Target & IC50
Others

Product References and Citations for Vazegepant HCl, inhibitor

Moreno-Ajona D, Abigail Perez-Rodriguez, Goadsby P J. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment,J]. Current Opinion in Neurology, 2020, 33(3):1.

Other Notes

Small volumes of Vazegepant HCl, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Vazegepant HCl purchase

MBS5759463 is an inhibitor targeting Vazegepant HCl.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000